GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emergent BioSolutions Inc (STU:ER4) » Definitions » E10

Emergent BioSolutions (STU:ER4) E10 : €0.10 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Emergent BioSolutions E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Emergent BioSolutions's adjusted earnings per share data for the three months ended in Mar. 2024 was €0.156. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.10 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Emergent BioSolutions's average E10 Growth Rate was -91.30% per year. During the past 3 years, the average E10 Growth Rate was -76.40% per year. During the past 5 years, the average E10 Growth Rate was -41.80% per year. During the past 10 years, the average E10 Growth Rate was -12.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Emergent BioSolutions was 21.00% per year. The lowest was -76.40% per year. And the median was 5.00% per year.

As of today (2024-05-23), Emergent BioSolutions's current stock price is €4.692. Emergent BioSolutions's E10 for the quarter that ended in Mar. 2024 was €0.10. Emergent BioSolutions's Shiller PE Ratio of today is 46.92.

During the past 13 years, the highest Shiller PE Ratio of Emergent BioSolutions was 169.50. The lowest was 4.53. And the median was 32.97.


Emergent BioSolutions E10 Historical Data

The historical data trend for Emergent BioSolutions's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emergent BioSolutions E10 Chart

Emergent BioSolutions Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.37 1.83 1.45 0.02

Emergent BioSolutions Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.15 0.68 0.15 0.02 0.10

Competitive Comparison of Emergent BioSolutions's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Emergent BioSolutions's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Emergent BioSolutions's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Emergent BioSolutions's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Emergent BioSolutions's Shiller PE Ratio falls into.



Emergent BioSolutions E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Emergent BioSolutions's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.156/131.7762*131.7762
=0.156

Current CPI (Mar. 2024) = 131.7762.

Emergent BioSolutions Quarterly Data

per share eps CPI Adj_EPS
201406 0.096 100.560 0.126
201409 0.380 100.428 0.499
201412 0.535 99.070 0.712
201503 -0.527 99.621 -0.697
201506 0.285 100.684 0.373
201509 0.704 100.392 0.924
201512 0.652 99.792 0.861
201603 0.090 100.470 0.118
201606 -0.240 101.688 -0.311
201609 0.401 101.861 0.519
201612 0.635 101.863 0.821
201703 0.215 102.862 0.275
201706 0.098 103.349 0.125
201709 0.571 104.136 0.723
201712 0.566 104.011 0.717
201803 -0.081 105.290 -0.101
201806 0.839 106.317 1.040
201809 0.351 106.507 0.434
201812 -0.062 105.998 -0.077
201903 -0.451 107.251 -0.554
201906 -0.159 108.070 -0.194
201909 0.754 108.329 0.917
201912 0.801 108.420 0.974
202003 -0.217 108.902 -0.263
202006 1.536 108.767 1.861
202009 0.620 109.815 0.744
202012 2.828 109.897 3.391
202103 1.075 111.754 1.268
202106 0.075 114.631 0.086
202109 -0.519 115.734 -0.591
202112 3.098 117.630 3.471
202203 -0.064 121.301 -0.070
202206 -1.069 125.017 -1.127
202209 -1.768 125.227 -1.860
202212 -1.661 125.222 -1.748
202303 -3.465 127.348 -3.585
202306 -4.753 128.729 -4.866
202309 -4.760 129.860 -4.830
202312 -0.871 129.419 -0.887
202403 0.156 131.776 0.156

Add all the adjusted EPS together and divide 10 will get our e10.


Emergent BioSolutions  (STU:ER4) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Emergent BioSolutions's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=4.692/0.1
=46.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Emergent BioSolutions was 169.50. The lowest was 4.53. And the median was 32.97.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Emergent BioSolutions E10 Related Terms

Thank you for viewing the detailed overview of Emergent BioSolutions's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Emergent BioSolutions (STU:ER4) Business Description

Traded in Other Exchanges
Address
400 Professional Drive, Suite 400, Gaithersburg, MD, USA, 20879
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based treatments; and contract development and manufacturing, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the United States government. Most revenue comes from U.S. government purchases of vaccines, devices, and therapeutic products. The company operates in two reportable segments; the Products Segment and the Services Segment.

Emergent BioSolutions (STU:ER4) Headlines

No Headlines